PKLR 抗体 (AA 1-574)
Quick Overview for PKLR 抗体 (AA 1-574) (ABIN7179041)
抗原
See all PKLR 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-574
- 
                                            交叉反应
- 人, 大鼠
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Rat Pyruvate kinase PKLR protein (1-574AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:500-1:5000,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - PKLR (Pyruvate Kinase, Liver and RBC (PKLR))
- 
                                            别名
- Pklr
- 
                                            背景
- 
                        Background: Plays a key role in glycolysis. Aliases: PklrPyruvate kinase PKLR antibody, EC 2.7.1.40 antibody, L-PK antibody, Pyruvate kinase isozymes L/R antibody 
- 
                                            UniProt
- P12928
- 
                                            途径
- Ribonucleoside Biosynthetic Process
 抗原
- 
                    
 
                                     
                                     
                                    